Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Changle Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical manufacturer specializing in the production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is recognized as one of the world's largest producers of caffeine and its derivatives, including theophylline and aminophylline, supplying these essential compounds to global markets. Based in Jiaozuo, Henan Province, it operates large-scale manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. As a subsidiary of the China National Pharmaceutical Group (Sinopharm), Changle Pharmaceutical plays a critical role in the supply chain for respiratory and central nervous system medications. The company serves both domestic and international clients, exporting products to over 60 countries and regions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chang Le Pharmaceutical.